We're publishing our most detailed threat intelligence report to date.
It covers how people tried to misuse Claude��for cyberattacks, influence operations, surveillance, biology, and building weapons—and how we found and stopped them.
We disrupted every operation in the report, and used the lessons from them to strengthen our safeguards. Where appropriate, we also shared what we found with authorities and other AI companies.
These cases are not typical: we’re highlighting some of the most sophisticated misuse we’ve seen. But they’re especially important to discuss, because they show us where AI misuse is headed, where our safeguards work, and where they need to improve.
We’re publishing this report so others can spot the same activity on their own platforms, and so we can give the public a clearer view of how emerging threats develop.
Read the report: https://t.co/0EJUnYEgfz
@ChuckCook I have a bot selling used stuff on Facebook marketplace for me. I just send him the photos, he will go look online for similar products' prices and write out all the descriptions and publish and negotiate on my behalf. I will only be notified where to meet
If you write a public piece with AI, you should disclose that in the first sentence:
“AI wrote this for me.”
unforgivable for a public figure to publish an AI-written piece without a clear disclosure in the first sentence.
🤦
Undermines the entire premise of publishing a thought piece, because we can’t tell what’s yours and what’s the magic black boxes’ thoughts.
Proofreading and research? Sure, have at it.
More from NOTUS: “Pangram, an AI detection tool, found that Druckenmiller’s op-ed had been written using artificial intelligence, according to multiple social media posts. In an interview with NOTUS, Druckenmiller said “of course I used AI” when writing the column, and argued he didn’t see a problem with doing so.
“There’s a reason I moved from an English major to being an economics major,” Druckenmiller said. “I’m not embarrassed by it … I write everything using AI now for the same reason I use a calculator when I do math problems.”
Moderna and @Merck today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene, a novel investigational mRNA-based individualized neoantigen therapy jointly developed by Merck and Moderna, in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in patients with completely resected Stage IIB-IV melanoma.
Read more:
China's economic data release yesterday was weak, and the consensus claimed it was “below expectations.” However, our leading indicator published for my research subscribers has been foretelling the slowdown for a while.
If we see a slowdown is coming, then it’s not a “disappointment”. Consensus didn't think hard enough. Not surprisingly, the market took yesterday’s weak data in stride.
The slowdown has some further to run. New lending has turned negative, and consumption is weak. At this juncture, the traditional RRR or interest rate cut won't do, as bond yields are at record lows but few are borrowing. Direct stimulus, such as tax cuts and cash subsidies, would work much better.
The Politburo Meeting in July acknowledged the external challenges and uncertainties but didn't elaborate on new policies. If conventional domestic policies are less effective and external demand (exports) is not influenced by domestic policies, then a new kind of stimulus is needed, and fast.
btw, there is really no need for them to merge. it is purely a window dressing. spcx and tsla are already great on their own. the only beneficiary will be Elon himself so that he can have control of Tesla.
if you still remember that WSJ article "Tesla is considering selling its china factory" (Elon denied it), it was a trial balloon. and spacex is a us government and defense contractor. by merging them, there will be geopolitical dramas
I fully expect $SPCX to make an all-equity offer at a healthy premium to acquire $TSLA sometime this year. It makes Elon’s life easier, and there are clearly shared synergies. My point: Many $TSLA shareholders will sell on any deal announcement rather than wait the 6-12 months for any deal to close. And most will not have to fortitude to stomach the approximate 50% SPCX dilution and watching the value of the SPCX equity to be delivered for their TSLA shares decline prior to any deal close.
It shouldn’t be lost on anyone how poorly $TSLA shares have performed YTD (TSLA -24% vs NDX +19%) despite high odds of this deal occurring.